BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34104028)

  • 41. Content Validation of the ATTR Amyloidosis Patient Symptom Survey: Findings from Patient and Clinician Cognitive Debriefing Interviews.
    Rizio AA; Broderick LE; White MK; Quock TP
    Patient Relat Outcome Meas; 2020; 11():149-160. PubMed ID: 32904695
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multidisciplinary Approaches for Transthyretin Amyloidosis.
    Koike H; Okumura T; Murohara T; Katsuno M
    Cardiol Ther; 2021 Dec; 10(2):289-311. PubMed ID: 34089151
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Case of Early Hereditary Transthyretin Amyloid Cardiomyopathy Recognition With Genetic Screening: A Case Report.
    Juarez M; Del Rio-Pertuz G; Parmar K; Bois MC; Shurmur S; Argueta-Sosa E
    J Prim Care Community Health; 2022; 13():21501319211062682. PubMed ID: 34983267
    [No Abstract]   [Full Text] [Related]  

  • 44. Transthyretin amyloidosis: an under-recognized neuropathy and cardiomyopathy.
    Galant NJ; Westermark P; Higaki JN; Chakrabartty A
    Clin Sci (Lond); 2017 Mar; 131(5):395-409. PubMed ID: 28213611
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis.
    Castano A; Haq M; Narotsky DL; Goldsmith J; Weinberg RL; Morgenstern R; Pozniakoff T; Ruberg FL; Miller EJ; Berk JL; Dispenzieri A; Grogan M; Johnson G; Bokhari S; Maurer MS
    JAMA Cardiol; 2016 Nov; 1(8):880-889. PubMed ID: 27557400
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ATTR Amyloidosis: Current and Emerging Management Strategies:
    Griffin JM; Rosenthal JL; Grodin JL; Maurer MS; Grogan M; Cheng RK
    JACC CardioOncol; 2021 Oct; 3(4):488-505. PubMed ID: 34729521
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Transthyretin Amyloidosis - Quality of Life (ATTR-QOL) Questionnaire: Development of a Conceptual Model and Disease-Specific Patient-Reported Outcome Measure.
    O'Connor M; Hsu K; Broderick L; McCausland KL; LaGasse K; Rebello S; Carty M; Lousada I
    Patient Relat Outcome Meas; 2023; 14():213-222. PubMed ID: 37441025
    [TBL] [Abstract][Full Text] [Related]  

  • 48.
    Kollikowski AM; Kahles F; Kintsler S; Hamada S; Reith S; Knüchel R; Röcken C; Mottaghy FM; Marx N; Burgmaier M
    Intractable Rare Dis Res; 2017 Nov; 6(4):291-294. PubMed ID: 29259858
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: a bivariate meta-analysis.
    Treglia G; Glaudemans AWJM; Bertagna F; Hazenberg BPC; Erba PA; Giubbini R; Ceriani L; Prior JO; Giovanella L; Slart RHJA
    Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1945-1955. PubMed ID: 29687207
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Transthyretin amyloidosis in a cohort of old and very old patients with chronic heart failure].
    Poliakova AA; Semernin EN; Sitnikova MY; Аvagyan KL; Grozov RV; Pyko SA; Krutikov AN; Davydova VG; Khmelnitskaya KA; Shavloskii MM; Korzhevskii DE; Gudkova AY
    Kardiologiia; 2018 SFeb; (S2):12-18. PubMed ID: 29782249
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Right ventricular involvement in transthyretin amyloidosis.
    Arvidsson S; Henein MY; Wikström G; Suhr OB; Lindqvist P
    Amyloid; 2018 Sep; 25(3):160-166. PubMed ID: 30193533
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Consensus recommendations on holistic care in hereditary ATTR amyloidosis: an international Delphi survey of patient advocates and multidisciplinary healthcare professionals.
    Obici L; Callaghan R; Ablett J; Bibiloni C; Bueser T; Conceição I; Dongiglio F; Farrugia A; Knebel F; Lane T; Larsson LO; Morier A; Nicholas V; Coelho T
    BMJ Open; 2023 Sep; 13(9):e073130. PubMed ID: 37669844
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid.
    Hutt DF; Fontana M; Burniston M; Quigley AM; Petrie A; Ross JC; Page J; Martinez-Naharro A; Wechalekar AD; Lachmann HJ; Quarta CC; Rezk T; Mahmood S; Sachchithanantham S; Youngstein T; Whelan CJ; Lane T; Gilbertson JA; Rowczenio D; Hawkins PN; Gillmore JD
    Eur Heart J Cardiovasc Imaging; 2017 Dec; 18(12):1344-1350. PubMed ID: 28159995
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patient-reported outcomes on familial amyloid polyneuropathy (FAP).
    Bolte FJ; Langenstroer C; Friebel F; Hüsing-Kabar A; Dugas M; Schmidt HH
    Orphanet J Rare Dis; 2020 Oct; 15(1):287. PubMed ID: 33054844
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Abdominal fat pad biopsies exhibit good diagnostic accuracy in patients with suspected transthyretin amyloidosis.
    Paulsson Rokke H; Sadat Gousheh N; Westermark P; Suhr OB; Anan I; Ihse E; Pilebro B; Wixner J
    Orphanet J Rare Dis; 2020 Oct; 15(1):278. PubMed ID: 33032630
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CMR-based differentiation of AL and ATTR cardiac amyloidosis.
    Dungu JN; Valencia O; Pinney JH; Gibbs SD; Rowczenio D; Gilbertson JA; Lachmann HJ; Wechalekar A; Gillmore JD; Whelan CJ; Hawkins PN; Anderson LJ
    JACC Cardiovasc Imaging; 2014 Feb; 7(2):133-42. PubMed ID: 24412186
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Step-by-step typing for the accurate diagnosis of concurrent light chain and transthyretin cardiac amyloidosis.
    Moriyama H; Kitakata H; Endo J; Ikura H; Sano M; Tasaki M; Sakai S; Ueda M; Fukuda K
    ESC Heart Fail; 2022 Apr; 9(2):1474-1477. PubMed ID: 35060353
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Carpal tunnel syndrome and spinal canal stenosis: harbingers of transthyretin amyloid cardiomyopathy?
    Aus dem Siepen F; Hein S; Prestel S; Baumgärtner C; Schönland S; Hegenbart U; Röcken C; Katus HA; Kristen AV
    Clin Res Cardiol; 2019 Dec; 108(12):1324-1330. PubMed ID: 30953182
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transthyretin amyloid deposits in lumbar spinal stenosis and assessment of signs of systemic amyloidosis.
    Eldhagen P; Berg S; Lund LH; Sörensson P; Suhr OB; Westermark P
    J Intern Med; 2021 Jun; 289(6):895-905. PubMed ID: 33274477
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice.
    Witteles RM; Bokhari S; Damy T; Elliott PM; Falk RH; Fine NM; Gospodinova M; Obici L; Rapezzi C; Garcia-Pavia P
    JACC Heart Fail; 2019 Aug; 7(8):709-716. PubMed ID: 31302046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.